Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity
- PMID: 18314065
- DOI: 10.1016/j.semradonc.2007.10.007
Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity
Abstract
Microarray analysis makes it possible to study the expression levels of tens of thousands of genes in one single experiment and is widely available for research purposes. Gene expression profiling is currently being used in many research projects aimed at identifying gene expression signatures in malignant tumors associated with prognosis and response to therapy. An important goal of such research is to develop gene expression-based diagnostic tests that can be used to guide therapy in cancer patients. Here we provide examples of studies using microarrays, especially focusing on breast cancer, in a wide range of fields including prediction of prognosis, distant metastasis and local recurrence, therapy response to radio- and chemotherapy, and normal tissue response.
Similar articles
-
Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.Expert Rev Mol Diagn. 2007 May;7(3):269-80. doi: 10.1586/14737159.7.3.269. Expert Rev Mol Diagn. 2007. PMID: 17489734 Review.
-
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507. doi: 10.1158/1078-0432.CCR-05-2734. Clin Cancer Res. 2007. PMID: 17255271
-
National Oncology Forum: perspectives for the year 2000.Cancer J. 2001 Jul-Aug;7 Suppl 1:S2-13. Cancer J. 2001. PMID: 11504281 Review.
-
[DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].Pathol Biol (Paris). 2006 Feb;54(1):49-54. doi: 10.1016/j.patbio.2005.02.003. Pathol Biol (Paris). 2006. PMID: 16376179 French.
-
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Int J Surg Pathol. 2009. PMID: 19103611 Review.
Cited by
-
Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.Cancer Res. 2009 Jul 15;69(14):5946-53. doi: 10.1158/0008-5472.CAN-09-0420. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584277 Free PMC article.
-
Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.Radiat Oncol. 2009 Jun 4;4:17. doi: 10.1186/1748-717X-4-17. Radiat Oncol. 2009. PMID: 19497124 Free PMC article.
-
The transcriptomic revolution and radiation biology.Int J Radiat Biol. 2022;98(3):428-438. doi: 10.1080/09553002.2021.1987562. Epub 2021 Oct 11. Int J Radiat Biol. 2022. PMID: 34586968 Free PMC article.
-
"OMIC" tumor markers for breast cancer: A review.Pak J Med Sci. 2015 Sep-Oct;31(5):1256-62. doi: 10.12669/pjms.315.7627. Pak J Med Sci. 2015. PMID: 26649025 Free PMC article. Review.
-
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.Cancer Res. 2012 May 1;72(9):2350-61. doi: 10.1158/0008-5472.CAN-11-4201. Epub 2012 Mar 6. Cancer Res. 2012. PMID: 22396490 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical